A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.


Updates from The Motley Fool

Latest updates on Celldex Therapeutics from Fool.com.


Stock Performance

CLDX vs. S&P 500 | 2 Year Performance
View Interactive CLDX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Celldex Therapeutics.
Current Price: $3.47
Prev Close: $3.50
Open: $3.55
Bid: $3.40
Ask: $3.49
Day's Range: $3.36 - $3.64
52wk Range: $2.96 - $18.62
Volume: 2,197,647
Avg Vol 2,118,259
Market Cap: $342.30M
P/E (ttm): -2.63
EPS (ttm): -$1.33
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Celldex Therapeutics.
CAPS Rating 4 out of 5
 
372 Outperform
18 Underperform
CAPS All Stars
 
59 Outperform
7 Underperform

How do you think Celldex Therapeutics will perform against the market?



You pick for Celldex Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Anthony S. Marucci, CEO

100% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Celldex Therapeutics.

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers